caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1831507367

Bob LiMBBS, MPH, FRACP

Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
285
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
16
Brand share
38.2%
Top prescribed drugs
Osimertinib Mesylate54 claims
Ondansetron Hcl22 claims
Megestrol Acetate20 claims
Dacomitinib17 claims
Dexamethasone16 claims
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
107
Unique beneficiaries
—
Total services
239
Distinct HCPCS
4
Medicare payment
$28K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — below median (cohort median 458).